AstraZeneca Says Has Submitted Full Data For European Approval Of...
From D&D 5e
Revision as of 07:10, 19 April 2021 by MurrayBrush1 (talk | contribs) (Created page with "<br>LONDON, [https://www.blog.gatenz-panel.com/ smm panel indonesia] Dec 30 (Reuters) - AstraZeneca has submitted full data to pursue a conditional marketing authorisation ap...")
LONDON, smm panel indonesia Dec 30 (Reuters) - AstraZeneca has submitted full data to pursue a conditional marketing authorisation application from the European Medicines Agency, a spokesman said on Wednesday after an EMA official said more data was needed.
"We can confirm that the we have submitted a full data package to support an application for conditional marketing authorisation for the AstraZeneca COVID-19 vaccine to the European Medicines Agency," the spokesman said.
"AstraZeneca has been submitting data on a rolling basis and will continue to work closely with the EMA to support the start of a formal CMA application process." (Reporting by Alistair Smout; editing by David Evans)